By John Richardson
WE LIVE in a highly interconnected world as this statistic underlines: of the $18tr worth of goods that were traded last year, intermediate goods or components of finished goods represented $11tr, according to the Organisation for Economic Cooperation and Development.
In the key automotive, textile, retail and construction petrochemical end-use industries, many intermediate products are made in developing countries outside China.
The developing world ex-China is of course also a major source of economic growth by itself, home to all the tens of millions of people who supposedly join the global middle class every year (in reality, though, this term is very misleading as middle class raises the notion of middle class by Western standards. As I have long argued, the reality in the developing world is very different).
Norway Commits to Donating COVID-19 Vaccines to Low-Income Countries
Dag Inge Ulstein says that equal vaccine distribution is in the best interest of every country.
Why Global Citizens Should Care:
Immunization will play an essential role in ending the COVID-19 pandemic. However, for the vaccines to work, everyone must have access to them, regardless of gender, race, age, socioeconomic status, or nationality. The United Nations is encouraging all countries to prioritize the global distribution of vaccines so that everyone can achieve quality health as a part of Global Goal 3. You can join Global Citizen by taking action here.
Norway’s Minister of International Development Dag Inge Ulstein tweeted on Monday that Norway will donate COVID-19 vaccine doses to the World Health Organization (WHO) and the ACT-Accelerator to ensure the equal distribution of the vaccine worldwide.
Date Time
At Duke, Future of Pathology Lies in AI
Researchers at Duke University have been merging artificial intelligence with health care to improve patient outcomes for the better part of two decades. From making cochlear implants deliver purer sounds to the brain to finding hidden trends within reams of patient data, the field spans a diverse range of niches that are now beginning to make real impacts.
Among these niches, however, there is one in which Duke researchers have always been at the leading edge-image analysis, with a broad team of researchers teaching computers to analyze images to unearth everything from various forms of cancer to biomarkers of Alzheimer’s disease in the retina.
DURHAM - Researchers at Duke University have been merging artificial intelligence with health care to improve patient outcomes for the better part of two